"At Mountain Blue Cancer Care Center we certainly share in our patient’s goals: Live longer and better. To reach these goals, we implement strategies that are unique and proven to be successful. For certain cancers, especially those at more advanced stages, the conventional treatment protocol is to use a combination of chemotherapy drugs that is “as aggressive as the patient can tolerate.” Although this strategy brought marginal improvement in survival, the quality of life and cost of treatment is less than optimal."

During the past decade, Mountain Blue Cancer Care Center conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 69 clinical trials were completed, i.e. on average, 61.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 49 clinical trials were completed. i.e. 222.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mountain Blue Cancer Care Center" #1 sponsor was "National Cancer Institute (NCI)" with 84 trials, followed by "SWOG Cancer Research Network" with 34 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mountain Blue Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 94 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Austrian Breast & Colorectal Cancer Study Group (ABCSG)" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Mountain Blue Cancer Care Center" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Mountain Blue Cancer Care Center" in a lesser frequency.

Most popular intervention types in "Mountain Blue Cancer Care Center" are "Drug" (141 trials), "Other" (118 trials), "Biological" (83 trials), "Procedure" (52 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (45 trials), "Biospecimen Collection" (28 trials), "Computed Tomography" (27 trials) and "Questionnaire Administration" (26 trials). Other intervention names were less common.

The vast majority of trials in "Mountain Blue Cancer Care Center" are 150 trials for "All" genders, 29 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mountain Blue Cancer Care Center". undefined are not yet recruiting, 47 are recruiting, 88 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Mountain Blue Cancer Care Center, 5 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Mountain Blue Cancer Care Center, 4 "Phase 1" clinical trials were conducted, 86 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".